Adverum Biotechnologies Operating Expenses 2011-2026 | ADVM

Annual Operating Expenses Adverum Biotechnologies

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
140 M	133 M	157 M	154 M	118 M	68.8 M	74.7 M	60.7 M	56 M	47.6 M	25 M	3.93 M	1.85 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
157 M	1.85 M	80 M

Quarterly Operating Expenses Adverum Biotechnologies

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
48 M	49.9 M	48.2 M	35.4 M	32.9 M	29.2 M	34.5 M	33.1 M	33.8 M	-	41 M	44 M	38.1 M	-	38.5 M	44.5 M	36.1 M	-	28 M	29.8 M	23.8 M	-	17.3 M	16.1 M	15.7 M	16.8 M	24.3 M	20.4 M	18.2 M	16.1 M	15 M	12.6 M	17 M	23.9 M	14.9 M	62.2 M	15.8 M	15.1 M	15.2 M	10.1 M	9.76 M	10.6 M	8.14 M	4.59 M	1.64 M	1.93 M	808 K	855 K	342 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
62.2 M	342 K	23.4 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Graybug Vision GRAY	23.1 M	-	-11.23 %	$ 9.65 M	USA
AbCellera Biologics ABCL	292 M	$ 3.64	-1.89 %	$ 1.09 B	Canada
ADMA Biologics ADMA	101 M	$ 16.45	0.43 %	$ 3.92 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
ANI Pharmaceuticals ANIP	127 M	$ 76.75	0.85 %	$ 1.48 B	USA
Apellis Pharmaceuticals APLS	948 M	$ 19.93	-1.14 %	$ 2.51 B	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Aptorum Group Limited APM	20.7 M	$ 0.83	4.23 %	$ 4.53 M	China
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
AVEO Pharmaceuticals AVEO	44.9 M	-	-	$ 521 M	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Burford Capital Limited BUR	106 M	$ 8.4	-1.81 %	$ 1.39 B	Britain
Axsome Therapeutics AXSM	99.1 M	$ 163.82	-0.14 %	$ 8.15 B	USA
BridgeBio Pharma BBIO	304 M	$ 66.98	3.8 %	$ 12.8 B	USA
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Caladrius Biosciences CLBS	23.4 M	-	-16.75 %	$ 25.8 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
BioLineRx Ltd. BLRX	28.1 M	$ 2.88	2.51 %	$ 908 M	Israel
Clovis Oncology CLVS	425 M	-	-7.23 %	$ 13 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
BioMarin Pharmaceutical BMRN	1.47 B	$ 60.75	3.79 %	$ 11.7 B	USA
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
CTI BioPharma Corp. CTIC	47.8 M	-	-	$ 1.2 B	USA
CohBar CWBR	12.4 M	-	-15.44 %	$ 2.2 M	USA
Cyclacel Pharmaceuticals CYCC	12 M	-	-5.98 %	$ 34.1 M	USA
Cyclacel Pharmaceuticals CYCCP	12 M	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Cabaletta Bio CABA	74.7 M	$ 3.41	4.77 %	$ 3.98 M	USA
Capricor Therapeutics CAPR	49.3 M	$ 25.71	-0.5 %	$ 688 M	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Codexis CDXS	31.5 M	$ 1.1	12.24 %	$ 80.7 M	USA
Certara CERT	237 M	$ 7.33	1.24 %	$ 1.18 B	USA
Entasis Therapeutics Holdings ETTX	52.3 M	-	-	$ 105 M	USA
Evofem Biosciences EVFM	104 M	-	7.55 %	$ 38.1 M	USA